Equities

Nanjing King-friend Biochemical Pharmaceutical Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Nanjing King-friend Biochemical Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)9.77
  • Today's Change0.01 / 0.10%
  • Shares traded16.38m
  • 1 Year change-26.87%
  • Beta1.2843
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

On Friday, Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707:SHH) closed at 9.77, 8.56% above its 52-week low of 9.00, set on Dec 31, 2025.
52-week range
Today
9.00Dec 31 202514.86Apr 01 2025
Open9.77
High9.90
Low9.68
Bid9.77
Offer9.78
Previous close9.76
Average volume14.86m
Shares outstanding1.62bn
Free float440.64m
P/E (TTM)23.93
Market cap15.77bn CNY
EPS (TTM)0.4079
CNY
Annual div (ADY)0.10
CNY
Annual div yield (ADY)1.02%
Div ex-dateJun 05 2025
Div pay-dateJun 05 2025
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.